Characteristics | No. of patients (%) |
---|---|
Age (years) a | |
≤ 45 | 130 (52.8) |
> 45 | 116 (47.2) |
Gender | |
Male | 196 (79.7) |
Female | 50 (20.3) |
Histology | |
WHO type I | 3 (1.2) |
WHO type II | 7 (2.8) |
WHO type III | 236 (96.0) |
EBV VCA-lgAb | |
≤ 320:1c | 100 (40.7) |
> 320:1 | 70 (28.5) |
EBV EA-lgAb | |
≤ 40:1d | 112 (45.5) |
> 40:1 | 58 (23.6) |
UICC T classification | |
T1-2 | 97 (39.4) |
T3-4 | 149 (60.6) |
UICC N classification | |
N0 | 41 (16.7) |
N1-3 | 205 (83.3) |
UICC M classification | |
M0 | 201 (81.7) |
M1 | 45 (18.3) |
Lung metastasis | |
DFI (years) | |
≤ 1 | 92 (37.4) |
1-3 | 86 (35.0) |
> 3 | 68 (27.6) |
Metastasis site | |
Unilateral | 118 (48.0) |
Bilateral | 128 (52.0) |
Metastasis number | |
Solitary | 82 (33.3) |
Multiple | 164 (66.7) |
Metastasis size (cm) e | |
≤ 2 | 147 (59.8) |
> 2 | 99 (40.2) |